Fundus autofluorescence and optical coherence tomography in relation to visual function in Usher syndrome type 1 and 2

Vision Research

Volumn 75, Issue , 2012, Pages 60-70

  Fakin, Ana ^a   Jarc Vidmar, Martina ^a   Glavač, Damjan ^b   Bonnet, Crystel ^c   Petit, Christine ^c,d,e   Hawlina, Marko ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c Institut Pasteur   (France)

^d INSTITUT PASTEUR   (France)

^e Centre de Recherche Interdisciplinaire en Biologie   (France)

Author keywords

Foveal patch; Fundus autofluorescence; Hyperautofluorescent ring; Optical coherence tomography; Retinitis pigmentosa; Usher syndrome

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOFLUORESCENCE IMAGING; BLINDNESS; CDH23 GENE; CHILD; COLOR VISION; CROSS-SECTIONAL STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; GENE; GENE MUTATION; GOLDMANN APPLANATION TONOMETER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MYO7A GENE; NIGHT BLINDNESS; ONSET AGE; OPTICAL COHERENCE TOMOGRAPHY; PCDH15 GENE; PERIMETRY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA FOVEA; RETINA MACULA CYSTOID EDEMA; SCHOOL CHILD; USH1C GENE; USH1G GENE; USH2A GENE; USHER GENE; USHER SYNDROME; USHER SYNDROME TYPE 1; USHER SYNDROME TYPE 2; VISUAL ACUITY; VISUAL FIELD; VISUAL SYSTEM EXAMINATION; VLGR1 GENE;

EID: 84871801750     PISSN: 00426989     EISSN: 18785646     Source Type: Journal    
DOI: 10.1016/j.visres.2012.08.017     Document Type: Article

References (37)

1. Aizawa S., Mitamura Y., Hagiwara A., Sugawara T., Yamamoto S. Changes of fundus autofluorescence, photoreceptor inner and outer segment junction line, and visual function in patients with retinitis pigmentosa. Clinical & Experimental Ophthalmology 2010, 38(6):597-604.
2. Bonnet C., El-Amraoui A. Usher syndrome (sensorineural deafness and retinitis pigmentosa): Pathogenesis, molecular diagnosis and therapeutic approaches. Current Opinion in Neurology 2011, 25(1):42-49.
3. Boughman J.A., Vernon M., Shaver K.A. Usher syndrome: Definition and estimate of prevalence from two high-risk populations. Journal of Chronic Diseases 1983, 36(8):595-603.
4. Cohen M., Bitner-Glindzicz M., Luxon L. The changing face of Usher syndrome: Clinical implications. International Journal of Audiology 2007, 46(2):82-93.
5. Cottet S., Schorderet D.F. Mechanisms of apoptosis in retinitis pigmentosa. Current Molecular Medicine 2009, 9(3):375-383.
6. Edwards A., Fishman G.A., Anderson R.J., Grover S., Derlacki D.J. Visual acuity and visual field impairment in Usher syndrome. Archives of Ophthalmology 1998, 116(2):165-168.
7. Fishman G.A., Anderson R.J., Lam B.L., Derlacki D.J. Prevalence of foveal lesions in type 1 and type 2 Usher's syndrome. Archives of Ophthalmology 1995, 113(6):770-773.
8. Fishman G.A., Bozbeyoglu S., Massof R.W., Kimberling W. Natural course of visual field loss in patients with Type 2 Usher syndrome. Retina 2007, 27(5):601-608.
9. Hood D.C., Lazow M.A., Locke K.G., Greenstein V.C., Birch D.G. The transition zone between healthy and diseased retina in patients with retinitis pigmentosa. Investigative Ophthalmology & Visual Science 2011, 52(1):101-108.
10. Hope C.I., Bundey S., Proops D., Fielder A.R. Usher syndrome in the city of Birmingham-Prevalence and clinical classification. British Journal of Ophthalmology 1997, 81(1):46-53.
11. Iannaccone A., Kritchevsky S.B., Ciccarelli M.L., Tedesco S.A., Macaluso C., Kimberling W.J., Somes G.W. Kinetics of visual field loss in Usher syndrome Type II. Investigative Ophthalmology & Visual Science 2004, 45(3):784-792.
12. Jacobson S.G., Cideciyan A.V., Aleman T.S., Sumaroka A., Roman A.J., Gardner L.M., Prosser H.M., Mishra M., Bech-Hansen N.T., Herrera W., Schwartz S.B., Liu X.Z., Kimberling W.J., Steel K.P., Williams D.S. Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism. Human Molecular Genetics 2008, 17(15):2405-2415.
13. Kimberling W.J., Moller C.G., Davenport S.L., Lund G., Grissom T.J., Priluck I., White V., Weston M.D., Biscone-Halterman K., Brookhouser P.E. Usher syndrome: Clinical findings and gene localization studies. Laryngoscope 1989, 99(1):66-72.
14. Lefevre G., Michel V., Weil D., Lepelletier L., Bizard E., Wolfrum U., Hardelin J.P., Petit C. A core cochlear phenotype in USH1 mouse mutants implicates fibrous links of the hair bundle in its cohesion, orientation and differential growth. Development 2008, 135(8):1427-1437.
15. Lenassi E., Troeger E., Wilke R., Hawlina M. Correlation between macular morphology and sensitivity in patients with retinitis pigmentosa and hyperautofluorescent ring. Investigative Ophthalmology & Visual Science 2012, 53(1):47-52.
16. Lima, L. H., Burke, T., Greenstein, V. C., Chou, C. L., Cella, W., Yannuzzi, L. A., et al. (2012). Progressive constriction of the hyperautofluorescent ring in retinitis pigmentosa. American Journal of Ophthalmology, 153(4), 718-727, 727, e711-712.
17. Maeda A., Maeda T., Golczak M., Palczewski K. Retinopathy in mice induced by disrupted all-trans-retinal clearance. Journal of Biological Chemistry 2008, 283(39):26684-26693.
18. Maerker T., van Wijk E., Overlack N., Kersten F.F., McGee J., Goldmann T., Sehn E., Roepman R., Walsh E.J., Kremer H., Wolfrum U. A novel Usher protein network at the periciliary reloading point between molecular transport machineries in vertebrate photoreceptor cells. Human Molecular Genetics 2008, 17(1):71-86.
19. Milam A.H., Li Z.Y., Fariss R.N. Histopathology of the human retina in retinitis pigmentosa. Progress in Retinal and Eye Research 1998, 17(2):175-205.
20. Millan J.M., Aller E., Jaijo T., Blanco-Kelly F., Gimenez-Pardo A., Ayuso C. An update on the genetics of usher syndrome. Journal of Ophthalmology 2011, 2011:417217.
21. Mitamura Y., Mitamura-Aizawa S., Nagasawa T., Katome T., Eguchi H., Naito T. Diagnostic imaging in patients with retinitis pigmentosa. Journal of Medical Investigation 2012, 59(1-2):1-11.
22. Murakami T., Akimoto M., Ooto S., Suzuki T., Ikeda H., Kawagoe N., Takahashi M., Yoshimura N. Association between abnormal autofluorescence and photoreceptor disorganization in retinitis pigmentosa. American Journal of Ophthalmology 2008, 145(4):687-694.
23. Piazza L., Fishman G.A., Farber M., Derlacki D., Anderson R.J. Visual acuity loss in patients with Usher's syndrome. Archives of Ophthalmology 1986, 104(9):1336-1339.
24. Popovic P., Jarc-Vidmar M., Hawlina M. Abnormal fundus autofluorescence in relation to retinal function in patients with retinitis pigmentosa. Graefes Archive for Clinical and Experimental Ophthalmology 2005, 243(10):1018-1027.
25. Robson A.G., Egan C., Holder G.E., Bird A.C., Fitzke F.W. Comparing rod and cone function with fundus autofluorescence images in retinitis pigmentosa. Advances in Experimental Medicine and Biology 2003, 533:41-47.
26. Robson A.G., Egan C.A., Luong V.A., Bird A.C., Holder G.E., Fitzke F.W. Comparison of fundus autofluorescence with photopic and scotopic fine-matrix mapping in patients with retinitis pigmentosa and normal visual acuity. Investigative Ophthalmology & Visual Science 2004, 45(11):4119-4125.
27. Robson, A. G., Lenassi, E., Saihan, Z., Luong, V., Fitzke, F., Holder, G. E., et al. (2012). Comparison of fundus autofluorescence with photopic and scotopic fine matrix mapping in patients with retinitis pigmentosa: 4- to 8-year follow-up. Investigative Ophthalmology & Visual Science.
28. Robson A.G., Saihan Z., Jenkins S.A., Fitzke F.W., Bird A.C., Webster A.R., Holder G.E. Functional characterisation and serial imaging of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. British Journal of Ophthalmology 2006, 90(4):472-479.
29. Robson A.G., Tufail A., Fitzke F., Bird A.C., Moore A.T., Holder G.E., Webster A.R. Serial imaging and structure-function correlates of high-density rings of fundus autofluorescence in retinitis pigmentosa. Retina 2011, 31(8):1670-1679.
30. Saihan Z., Webster A.R., Luxon L., Bitner-Glindzicz M. Update on Usher syndrome. Current Opinion in Neurology 2009, 22(1):19-27.
31. Sandberg M.A., Rosner B., Weigel-DiFranco C., McGee T.L., Dryja T.P., Berson E.L. Disease course in patients with autosomal recessive retinitis pigmentosa due to the USH2A gene. Investigative Ophthalmology & Visual Science 2008, 49(12):5532-5539.
32. Seeliger M., Pfister M., Gendo K., Paasch S., Apfelstedt-Sylla E., Plinkert P., Zenner H.P., Zrenner E. Comparative study of visual, auditory, and olfactory function in Usher syndrome. Graefes Archive for Clinical and Experimental Ophthalmology 1999, 237(4):301-307.
33. Sparrow J.R., Yoon K.D., Wu Y., Yamamoto K. Interpretations of fundus autofluorescence from studies of the bisretinoids of the retina. Investigative Ophthalmology & Visual Science 2010, 51(9):4351-4357.
34. Tsilou E.T., Rubin B.I., Caruso R.C., Reed G.F., Pikus A., Hejtmancik J.F., Iwata F., Redman J.B., Kaiser-Kupfer M.I. Usher syndrome clinical types I and II: Could ocular symptoms and signs differentiate between the two types?. Acta Ophthalmologica Scandinavica 2002, 80(2):196-201.
35. van Soest S., Westerveld A., de Jong P.T., Bleeker-Wagemakers E.M., Bergen A.A. Retinitis pigmentosa: Defined from a molecular point of view. Survey of Ophthalmology 1999, 43(4):321-334.
36. Wakabayashi T., Sawa M., Gomi F., Tsujikawa M. Correlation of fundus autofluorescence with photoreceptor morphology and functional changes in eyes with retinitis pigmentosa. Acta Ophthalmologica 2010, 88(5):e177-e183.
37. Williams D.S. Usher syndrome: Animal models, retinal function of Usher proteins, and prospects for gene therapy. Vision Research 2008, 48(3):433-441.